Polyphor AG | WebDisclosure

Basculer en Français

8295	Companies
114858	Keywords
55302	Articles
62445	Press releases

Home
Companies
Polyphor AG

BRIEF

published on 07/08/2024 at 07:20, 4 months 13 days ago

Spexis AG : PARI Pharma GmbH annonce la résiliation de la licence ColiFin® d'EnBiotix, Inc.

Spexis SA PARI Pharma ColiFin® EnBiotix, Inc. Restructuration De Dettes
PRESS RELEASE

published on 07/08/2024 at 07:15, 4 months 13 days ago

Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc.
PARI Pharma GmbH terminates ColiFin® license to EnBiotix, Inc. Spexis AG deals with debt-restructuring amid license termination

Spexis AG ColiFin® Debt-restructuring PARI Pharma GmbH License Termination
BRIEF

published on 06/04/2024 at 20:05, 5 months 16 days ago

Spexis fait appel de la suspension de ses actions à la SIX Exchange

Rapport Annuel Appel Spexis SA Bourse SIX Suspension Des Actions
BRIEF

published on 06/04/2024 at 20:05, 5 months 16 days ago

Spexis Appeals Suspension of its Shares on SIX Exchange

Annual Report Spexis AG Appeal SIX Exchange Shares Suspension
PRESS RELEASE

published on 06/04/2024 at 20:00, 5 months 16 days ago

Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares.
Spexis AG launches appeal against trading suspension decision by SIX Exchange Regulation regarding its shares due to audit report publication delay

Spexis AG SIX Exchange Regulation Trading Suspension Audit Report Shareholder Appeal
BRIEF

published on 05/31/2024 at 22:05, 5 months 20 days ago

Spexis a obtenu une prolongation pour son rapport annuel 2023 au milieu d'un différend avec SPRIM

États Financiers Rapport Annuel Spexis SPRIM Bourse SIX
BRIEF

published on 05/31/2024 at 22:05, 5 months 20 days ago

Spexis Granted Extension for 2023 Annual Report Amid Dispute with SPRIM

Financial Statements Annual Report Spexis SPRIM SIX Exchange
PRESS RELEASE

published on 05/31/2024 at 22:00, 5 months 20 days ago

Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
Spexis receives second extension from SIX Exchange Regulation AG to publish its 2023 annual report by July 31, 2024, providing unaudited financial statements and an update on the dispute with SPRIM

Extension 2023 Annual Report Spexis AG Unaudited Financial Statements Dispute With SPRIM
BRIEF

published on 04/30/2024 at 20:35, 6 months 20 days ago

Spexis AG Granted Extension for 2023 Annual Report Submission

Biopharmaceuticals Spexis AG SIX Exchange Regulation Annual Report Delay Corporate Compliance
BRIEF

published on 04/30/2024 at 20:35, 6 months 20 days ago

Spexis AG obtient une prolongation pour la soumission du rapport annuel 2023

Produits Biopharmaceutiques SIX Exchange Réglementation Retard Du Rapport Annuel Spexis SA Conformité D'entreprise

Accesswire

Published on 11/21/2024 at 12:00, 35 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 35 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 5 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 32 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 35 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:15, 20 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 28 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 35 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 5 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 34 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 37 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 37 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 37 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 27 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 15 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE